title: Rituximab treatment for posttransplantation lymphoproliferative disorder after small bowel transplantation.
authors.affiliation: Department of Surgery, University of Miami School of Medicine, Miami, Florida 33136, USA.
authors.forename: S
authors.initials: S
authors.lastname: Nishida
authors.forename: T
authors.initials: T
authors.lastname: Kato
authors.forename: T
authors.initials: T
authors.lastname: Burney
authors.forename: D
authors.initials: D
authors.lastname: Levi
authors.forename: J
authors.initials: J
authors.lastname: Nery
authors.forename: J
authors.initials: J
authors.lastname: Madariaga
authors.forename: N
authors.initials: N
authors.lastname: Mittal
authors.forename: D
authors.initials: D
authors.lastname: Weppler
authors.forename: P
authors.initials: P
authors.lastname: Ruiz
authors.forename: A
authors.initials: A
authors.lastname: Tzakis
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007223:Infant; D007421:Intestine, Small / Q000637:transplantation*; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy*; D012189:Retrospective Studies; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab